Radiological risk assessment of capstone depleted uranium aerosols

Health Physics

Volumn 96, Issue 3, 2009, Pages 352-362

  Hahn, Fletcher F ^a   Roszell, Laurie E ^b   Daxon, Eric G ^c   Guilmette, Raymond A ^a   Parkhurst, Mary Ann ^d  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Health effects; Inhalation; Radiation risk; Uranium, depleted

Indexed keywords

CAPSTONE DEPLETED URANIUM; UNCLASSIFIED DRUG; URANIUM;

ADOLESCENT; ADULT; AEROSOL; AGED; ARMY; ARTICLE; BLADDER CANCER; BONE CANCER; BONE MARROW CANCER; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CHILD; COLON CANCER; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PROTECTION; ESOPHAGUS CANCER; HEALTH HAZARD; HUMAN; INFANT; KIDNEY; KIDNEY CANCER; LARYNX; LIVER CANCER; LUNG; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOTOR VEHICLE; MOUTH; NEWBORN; NOSE; OCCUPATIONAL EXPOSURE; OVARY CANCER; PHARYNX; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOLOGICAL PROCEDURES; RISK ASSESSMENT; SCHOOL CHILD; SKIN CANCER; SOLDIER; STOMACH CANCER; THORAX CANCER; THYROID CANCER; VENTILATOR; AIR POLLUTION; ALGORITHM; BETA RADIATION; COMPUTER SIMULATION; FIREARM; INCIDENCE; RADIATION INJURY; RADIATION MONITORING; RADIOACTIVE WASTE; RISK FACTOR; STATISTICS; UNITED STATES; WAR;

AEROSOLS; AIR POLLUTION, RADIOACTIVE; ALGORITHMS; BETA RAYS; COMPUTER SIMULATION; FIREARMS; GULF WAR; HUMANS; INCIDENCE; MILITARY PERSONNEL; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RADIATION INJURIES; RADIATION MONITORING; RADIOACTIVE WASTE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; URANIUM;

EID: 62149099592     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hp.0000318891.68749.66     Document Type: Article

References (42)

1. Agency for Toxic Substances and Disease Registry. Toxicological profile for uranium. Atlanta, GA: U.S. Department of Health and Human Services; ATSDR Report TP 90-29; 1999.
2. American Cancer Society. American Cancer Society, cancer facts and figures, 2007. Atlanta, GA: American Cancer Society; 2007.
3. Donoghue JK, Dyson ED, Hislop JS, Leach AM, Spoor NL. Human exposure to natural uranium. Brit J Industrial Med 29:81-89; 1972.
4. Dupree EA, Watkins JP, Ingle JN, Wallace PW, West CM, Tankersley WG. Uranium dust exposure and lung cancer risk in four uranium processing operations. Epidemiol 6:370-375; 1995.
5. Durbin PW. Metabolic models for uranium. In: Moore TH, ed. Biokinetics and analysis of uranium in man. Springfield, VA: National Technical Information Service; U.S. Transuranium Registry; USUR-05, HEHF-47, F1-F65; 1984.
6. Freid V, Prager K, Mackay A, Xia H. Chartbook on trends in the health of Americans. Hyattsville, MD: National Center for Health Statistics; 2003.
7. Fulco CE, Liverman CT, Sox HC. Depleted uranium. In: Gulf war and health, Vol.1, chapter 4. Washington, DC: National Academy Press; 2000: 89-167.
8. 239,240Plutonium by humans: a combined four-method approach with uncertainty evaluation. Health Phys 80:447-461; 2001.
9. Guilmette RA, Parkhurst MA, Miller G, Hahn FF, Roszell LE, Daxon EG, Little TT, Whicker JJ, Cheng YS, Traub RJ, Lodde GM, Szrom F, Bihl DE, Creek KL, McKee CB. Human health risk assessment of Capstone depleted uranium aerosols. Columbus, OH: Battelle Press; 2005. Available at: http://fhp.osd.mil/du/du- capstone/index.pdf as attachment 3 to Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments. Accessed 22 November 2008.
10. Guilmette RA, Miller G, Parkhurst MA. Capstone depleted uranium aerosol biokinetics, concentrations, and doses. Health Phys 96:328-342; 2009.
11. Hahn FF, Muggenburg BA, Guilmette RA, Boecker BB. Comparative stochastic effects of inhaled alpha-and betaemitting radionuclides in beagle dogs. Radiat Res 152:S19- S22; 1999.
12. Harley NH, Foulkes, EC, Hilborne LH, Hudson A, Anthony CR. A review of the scientific literature as it pertains to Gulf War illnesses: Volume 7, depleted uranium. Santa Monica, CA: RAND; MR-1018/7-OSD; 1999.
13. Hodge HC, Stannard JN, Hursh JB. Uranium, plutonium, transplutonium elements. Handbook of experimental pharmacology. Vol.36. New York: Springer-Verlag; 1973.
14. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon Press; ICRP Publication 60; 1991.
15. International Commission on Radiological Protection. Human respiratory tract model for radiological protection. Oxford: Pergamon Press; ICRP Publication 66; 1994.
16. International Commission on Radiological Protection. Agedependent doses to members of the public from intake of radionuclides: Part 3: ingestion dose coefficients. Oxford: Pergamon Press; ICRP Publication 69; 1995.
17. Kathren RL, McInroy JF, Moore RH, Dietert SE. Uranium in the tissues of an occupationally exposed individual. Health Phys 57:17-21; 1989.
18. Koshurnikova NA, Bolotnikova MG, Ilyin LA, Keirim-Markus IB, Menshikh ZS, Okatenko PV, Romanov SA, Tsvetkov VI, Shilnikova NS. Lung cancer risk due to exposure to incorporated plutonium. Radiat Res 149:366-371; 1998.
19. 2) dust-II. Postexposure retention and biologic effect in the monkey, dog, and rat. Health Phys 25:239-258; 1973.
20. Lloyd RD, Taylor GN, Fisher DR, Schlenker RA, Miller SC. Effective thresholds for induction of skeletal malignancies by radionuclides. Health Phys 79:722-727; 2000.
21. Maxfield BD. Army demographics: FY02 army profile [online]. Washington, DC: U.S. Army; Headquarters Department of Army, Deputy Chief of Staff of Personnel; G-12002; 2002. Available at: http://www.armyg1.army.mil/ hr/demographics/FY02ArmyProfile.pdf. Accessed 15 January 2004.
22. Mays CW, Rowland RE, Stehney AF. Cancer risk from the lifetime intake of Ra and U isotopes. Health Phys 48:635- 647; 1985.
23. Miller AC. Depleted uranium: properties, uses and health consequences. Boca Raton, FL: Taylor and Francis; 2007.
24. Miller AC, Stewart M, Brooks K, Shi L, Page N. Depleted uranium-catalyzed oxidative DNA damage: absence of significant alpha decay. J Inorganic Biochem 91:246-252; 2002. (Pubitemid 34741945)
25. Miller G, Cheng YS, Traub RJ, Little TT, Guilmette RA. Methods used to calculate doses resulting from inhalation of Capstone depleted uranium aerosols. Health Phys 96:306-327; 2009.
26. National Council on Radiation Protection and Measurements. Risk estimates for radiation protection. Bethesda, MD: NCRP; Publication 115; 1993.
27. National Research Council. Uranium in health risks of radon and other internally deposited alpha-emitters. Washington, DC: National Academy Press; National Research Council, Committee on the Biological Effects of Ionizing Radiations; BEIR IV; 1988.
28. Parkhurst MA, Guilmette RA. Overview of the Capstone depleted uranium study of aerosols from impact with armored vehicles: test setup and aerosol generation, characterization, and application in assessing dose and risk. Health Phys 96:207-220; 2009.
29. Parkhurst MA, Szrom F, Guilmette RA, Holmes TD, Cheng YS, Kenoyer JL, Collins JW, Sanderson TE, Fliszar RW, Gold K, Beckman JC, Long JA. Capstone depleted uranium aerosols: generation and characterization, volumes 1 and 2. Richland, WA: Pacific Northwest National Laboratory; PNNL-14168; 2004. Available at: http://fhp.osd.mil/du/ du-capstone/index.pdf as attachments 1 and 2 to Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments. Accessed 22 November 2008.
30. Puskin JS, Nelson CB. Estimates of radiogenic cancer risks. Health Phys 69:93-101; 1995.
31. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Fay MP, Feuer EJ, Edwards BD. SEER cancer statistics review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003. Available at: http://seer. cancer.gov/csr/1975-2000,2003. Accessed January 2004.
32. Ritz B. Radiation exposure and cancer mortality in uranium processing workers. Epidemiol 10:531-538; 1999. (Pubitemid 29398910)
33. Roszell LE, Hahn FF, Lee RB, Parkhurst MA. Assessing the renal toxicity of depleted uranium oxides and other uranium compounds. Health Phys 96:343-351; 2009.
34. Rowland RE. Dose-response relationships for female radium dial workers: a new look. In: Van Kaick G, Karaoglou A, Keller AM, eds. Health effects of internally deposited radionuclides: emphasis on radium and thorium. Singapore: World Scientific; 1995: 135-144.
35. Singh NP, Bennett DD, Wrenn ME. Concentrations of α-emitting isotopes of U and Th in uranium miners' and millers' tissues. Health Phys 53:261-265; 1987.
36. Tannenbaum A. Toxicology of uranium. National Nuclear Energy Series. New York: Mcgraw-Hill Book Company; 1951.
37. The Royal Society. The health hazards of depleted uranium munitions part I [online]. London: The Royal Society; Policy Document 6/01; 2001. Available at: http://royalsociety. org/displaypagedoc.asp?id=11496. Accessed 10 January 2009.
38. The Royal Society. The health hazards of depleted uranium munitions part II [online]. London: The Royal Society; Policy Document 5/02; 2002. Available at: http://royalsociety. org/displaypagedoc.asp?id=11498. Accessed 10 January 2009.
39. U.S. Environmental Protection Agency. Cancer risk coefficients for environmental exposure to radionuclides (CD supplement). Oak Ridge, TN: Oak Ridge National Laboratory; Federal Guidance Report 13; EPA 402-C-99-1001, rev. 1; 2002.
40. Voegtlin C, Hodge HC. The pharmacology and toxicology of uranium compounds. National Nuclear Energy Series, volumes 1 and 2. New York: McGraw-Hill Book Company; 1949.
41. Voegtlin C, Hodge HC. The pharmacology and toxicology of uranium compounds. National Nuclear Energy Series, volumes 3 and 4. New York: McGraw-Hill Book Company; 1953.
42. World Health Organization. Depleted uranium: sources, exposure, and health effects [online]. Geneva: WHO; Department of the Protection of the Human Environment; WHO/ SDE/PHE/01.1; 2001. Available at: http://www.who.int/ ionizing-radiation/env/du/en/. Accessed 22 November 2008.